[HTML][HTML] Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID
JW Seo, SE Kim, Y Kim, EJ Kim, T Kim… - Infection & …, 2024 - ncbi.nlm.nih.gov
Abstract" Long COVID" is a term used to describe a condition when the symptoms and signs
associated with coronavirus disease 2019 (COVID-19) persist for more than three months …
associated with coronavirus disease 2019 (COVID-19) persist for more than three months …
Characteristics of long COVID and the impact of COVID-19 vaccination on long COVID 2 years following COVID-19 infection: prospective cohort study
Y Kim, S Bae, HH Chang, SW Kim - Scientific Reports, 2024 - nature.com
This prospective cohort study aimed to identify characteristics of long COVID and any
potential mitigating effects of COVID-19 vaccinations in patients 24 months following COVID …
potential mitigating effects of COVID-19 vaccinations in patients 24 months following COVID …
Predictive attributes for developing long COVID—a study using machine learning and real-world data from primary care physicians in Germany
R Kessler, J Philipp, J Wilfer, K Kostev - Journal of Clinical Medicine, 2023 - mdpi.com
(1) In the present study, we used data comprising patient medical histories from a panel of
primary care practices in Germany to predict post-COVID-19 conditions in patients after …
primary care practices in Germany to predict post-COVID-19 conditions in patients after …
[HTML][HTML] Impact of Long SARS-CoV-2 Omicron Infection on the Health Care Burden: Comparative Case-Control Study Between Omicron and Pre-Omicron Waves
B Valdivieso-Martinez… - JMIR Public Health …, 2024 - publichealth.jmir.org
Background: Following the initial acute phase of COVID-19, health care resource use has
escalated among individuals with SARS-CoV-2 infection. Objective: This study aimed to …
escalated among individuals with SARS-CoV-2 infection. Objective: This study aimed to …
The new frontier: Clinical consequences of long COVID
JA Bellanti - Journal of Precision Respiratory Medicine, 2023 - ingentaconnect.com
Background: After infection with severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), a variety of clinical outcomes have been known to occur, ranging from asymptomatic …
CoV-2), a variety of clinical outcomes have been known to occur, ranging from asymptomatic …
The Effectiveness and Safety of Nafamostat Mesylate in the Treatment of COVID-19: a Meta-Analysis
M Wei, T Li, S Liu, Y Wang, C Tran… - Japanese Journal of …, 2024 - jstage.jst.go.jp
抄録 Nafamostat mesylate, a synthetic serine protease inhibitor, has been shown to have
antiviral activity against SARS-CoV-2 and anticoagulant properties that may be beneficial in …
antiviral activity against SARS-CoV-2 and anticoagulant properties that may be beneficial in …
[PDF][PDF] Impact of Long SARS-CoV-2 Omicron on Health Care Burden: A Case-control Comparative Study with the Pre-Omicron Waves
J Redon, B Valdivieso-Martinez, V Lopez-Sanchez… - s3.ca-central-1.amazonaws.com
Background: The global population has been profoundly affected by the SARS-CoV-2
pandemic, resulting in elevated morbidity and mortality. Following the initial acute phase of …
pandemic, resulting in elevated morbidity and mortality. Following the initial acute phase of …